Samsung Medical Center

Collaborates to jointly develop a treatment (to prevent natural muscle cell loss and enhance muscle growth) targeting Duchenne Muscular Dystrophy (DMD) (a rare disease affecting one in 3,500 boys caused by dystrophin gene mutations, leading to progressive muscle loss and early mortality before the age of 20)

Gachon University GIL Medical Center

Joint development of treatments for type 2 diabetes
: preparing to sign MoU for collaborative R&D using probiotics with myostatin expressed on the cell surface as target antigens based on GOST technology.

Eulji Mecial Center, Eulji University

Jointly developing cancer immunotherapy for humans
: developing an active immune inducer that targets self-proteins as antigens to neutralize immune checkpoint inhibitors.

College of Veterinary Medicine, Chungnam National University

Collaborating on a joint R&D project to develop cancer immunotherapy for companion dogs.

Korea Research Institute of Bioscience and Biotechnology (KRIBB)

Transferred three proprietary technologies for developing cell surface-expressed probiotics, which served as the foundation to develop F&T’s core technologies and to enhance the immune probiotic hosts.

College of Medicine, Chungbuk National University

Collaborative research in the prevention, treatment, and vaccine development for zoonotic diseases, including avian influenza.